Alterity Therapeutics (ATHE) vs Pliant Therapeutics (PLRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alterity Therapeutics (ATHE) has outperformed Pliant Therapeutics (PLRX) over the past year, losing 22.4% versus a loss of 33.1%. Over five years, ATHE leads with a -74.7% price change compared with -94.5% for PLRX. Pliant Therapeutics is the larger company by market cap ($61.1 million vs $56.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATHE | PLRX |
|---|---|---|
| Share price | $3.10 | $0.9861 |
| Market cap | $56.45M | $61.06M |
| 1-day change | -6.63% | -0.39% |
| YTD return | +7.79% | -18.85% |
| 1-year return | -22.43% | -33.11% |
| 5-year return | -74.66% | -94.50% |
| EPS (TTM) | $-0.90 | $-1.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $1.95 |
| 52-week low | $2.66 | $0.97 |
| Distance from 52-week high | -47.37% | -49.43% |
| Average volume | 16.33K | 492.25K |
| Shares outstanding | 18.21M | 61.92M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATHE has outperformed PLRX by 10.7 percentage points over the past year.
ATHE vs PLRX FAQ
Which is bigger, Alterity Therapeutics or Pliant Therapeutics?
Pliant Therapeutics (PLRX) is larger, with a market capitalization of $61.06M compared with $56.45M for Alterity Therapeutics (ATHE).
Which stock has performed better over the past year, ATHE or PLRX?
ATHE returned -22.43% over the past 12 months, compared with -33.11% for PLRX (price return, excluding dividends). Past performance does not predict future results.
Are Alterity Therapeutics and Pliant Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.